Low-dose interleukin-2 and HCV-induced vasculitis

New England Journal of Medicine

Volumn 366, Issue 14, 2012, Pages 1353-1354

  Oo, Ye Htun ^a   Mutimer, David ^a   Adams, David H ^a  

^a Centre for Liver Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; IN VIVO STUDY; LETTER; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; VASCULITIS;

EID: 84859408780     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1200978     Document Type: Letter

References (5)

1. Saadoun D, Rosenzwajg M, Joly F, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 2011;365:2067-77.
2. Bluestone JA. Mechanisms of tolerance. Immunol Rev 2011; 241:5-19.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
4. Rubtsov YP, Niec RE, Josefowicz S, et al. Stability of the regulatory T cell lineage in vivo. Science 2010;329:1667-71.
5. Oo YH, Weston CJ, Lalor PF, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 2010;184:2886-98.